These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 27569438

  • 21. Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials.
    Hijazi Z, Oldgren J, Lindbäck J, Alexander JH, Alings M, De Caterina R, Eikelboom JW, Ezekowitz MD, Held C, Huber K, Hylek EM, Granger CB, Lopes RD, Vinereanu D, Siegbahn A, Wallentin L.
    JAMA Netw Open; 2020 Sep 01; 3(9):e2015943. PubMed ID: 32936298
    [Abstract] [Full Text] [Related]

  • 22. ABC-AF-Stroke score predicts thromboembolism in non-anticoagulated patients following successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry.
    Wang Y, Jiang C, He L, Du X, Guo X, Tang R, Sang C, Long D, Dong J, Hijazi Z, Lip GYH, Ma C.
    Chin Med J (Engl); 2023 Oct 20; 136(20):2451-2458. PubMed ID: 37858319
    [Abstract] [Full Text] [Related]

  • 23. High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined Source.
    Scheitz JF, Pare G, Pearce LA, Mundl H, Peacock WF, Czlonkowska A, Sharma M, Nolte CH, Shoamanesh A, Berkowitz SD, Krahn T, Endres M, NAVIGATE-ESUS Biomarker Working Group.
    Stroke; 2020 Aug 20; 51(8):2386-2394. PubMed ID: 32640945
    [Abstract] [Full Text] [Related]

  • 24. Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy.
    Hijazi Z, Siegbahn A, Andersson U, Lindahl B, Granger CB, Alexander JH, Atar D, Gersh BJ, Hanna M, Harjola VP, Horowitz J, Husted S, Hylek EM, Lopes RD, McMurray JJ, Wallentin L.
    Clin Chem; 2015 Feb 20; 61(2):368-78. PubMed ID: 25451868
    [Abstract] [Full Text] [Related]

  • 25. Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure.
    Tsutamoto T, Kawahara C, Nishiyama K, Yamaji M, Fujii M, Yamamoto T, Horie M.
    Am Heart J; 2010 Jan 20; 159(1):63-7. PubMed ID: 20102868
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas.
    Pol T, Hijazi Z, Lindbäck J, Alexander JH, Bahit MC, De Caterina R, Eikelboom JW, Ezekowitz MD, Gersh BJ, Granger CB, Hylek EM, Lopes R, Siegbahn A, Wallentin L.
    Open Heart; 2021 Mar 20; 8(1):. PubMed ID: 33741689
    [Abstract] [Full Text] [Related]

  • 28. Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores.
    Rivera-Caravaca JM, Marín F, Vilchez JA, Gálvez J, Esteve-Pastor MA, Vicente V, Lip GYH, Roldán V.
    Stroke; 2019 Jun 20; 50(6):1372-1379. PubMed ID: 31084333
    [Abstract] [Full Text] [Related]

  • 29. Neurofilament Light Chain and Risk of Stroke in Patients With Atrial Fibrillation.
    Aulin J, Sjölin K, Lindbäck J, Benz AP, Eikelboom JW, Hijazi Z, Kultima K, Oldgren J, Wallentin L, Burman J, ACTIVE A and AVERROES Investigators.
    Circulation; 2024 Oct 20; 150(14):1090-1100. PubMed ID: 39045686
    [Abstract] [Full Text] [Related]

  • 30. High-sensitivity cardiac troponin T levels and risk of cerebral microbleeds in acute ischemic stroke patients with atrial fibrillation and/or rheumatic heart disease.
    Liu J, Wang D, Xiong Y, Liu B, Wei C, Ma Z, Wu B, Tang H, Liu M.
    J Neurol Sci; 2016 Oct 15; 369():15-18. PubMed ID: 27653858
    [Abstract] [Full Text] [Related]

  • 31. Circulating cardiac biomarkers and postoperative atrial fibrillation in the OPERA trial.
    Masson S, Wu JH, Simon C, Barlera S, Marchioli R, Mariani J, Macchia A, Lombardi F, Vago T, Aleksova A, Dreas L, Favaloro RR, Hershson AR, Puskas JD, Dozza L, Silletta MG, Tognoni G, Mozaffarian D, Latini R, OPERA Investigators.
    Eur J Clin Invest; 2015 Feb 15; 45(2):170-8. PubMed ID: 25510286
    [Abstract] [Full Text] [Related]

  • 32. Cardiac biomarkers are associated with increased risks of adverse clinical outcomes after ischemic stroke.
    Chang X, Xia S, Liu Y, Mao X, Wu X, Chu M, Niu H, Sun L, He Y, Liu Y, Guo D, Shi M, Zhang Y, Zhu Z, Zhao J.
    J Neurol; 2024 Sep 15; 271(9):6313-6324. PubMed ID: 39105893
    [Abstract] [Full Text] [Related]

  • 33. Letter by Bonaque et al regarding article, "Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a randomized evaluation of long-term anticoagulation therapy (RE-LY) substudy".
    Bonaque JC, Merchán G, Ikuta I.
    Circulation; 2013 Jan 15; 127(2):e277. PubMed ID: 23319819
    [No Abstract] [Full Text] [Related]

  • 34. Response to letter regarding article, "Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a randomized evaluation of long-term anticoagulation therapy (RE-LY) substudy".
    Hijazi Z, Oldgren J, Wallentin L, Andersson U, Connolly SJ, Yusuf S, Ezekowitz MD, Hohnloser SH, Reilly PA, Vinereanu D, Siegbahn A.
    Circulation; 2013 Jan 15; 127(2):e278-9. PubMed ID: 23437443
    [No Abstract] [Full Text] [Related]

  • 35. Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial.
    Gravning J, Askevold ET, Nymo SH, Ueland T, Wikstrand J, McMurray JJ, Aukrust P, Gullestad L, Kjekshus J, CORONA Study Group.
    Circ Heart Fail; 2014 Jan 15; 7(1):96-103. PubMed ID: 24284025
    [Abstract] [Full Text] [Related]

  • 36. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M, Lupon J, Galan A, Vila J, Urrutia A, Bayes-Genis A.
    Am Heart J; 2012 May 15; 163(5):821-8. PubMed ID: 22607860
    [Abstract] [Full Text] [Related]

  • 37. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.
    Gravning J, Smedsrud MK, Omland T, Eek C, Skulstad H, Aaberge L, Bendz B, Kjekshus J, Mørkrid L, Edvardsen T.
    Am Heart J; 2013 May 15; 165(5):716-24. PubMed ID: 23622908
    [Abstract] [Full Text] [Related]

  • 38. Early release of high-sensitive cardiac troponin during complex catheter ablation for ventricular tachycardia and atrial fibrillation.
    Reichlin T, Lockwood SJ, Conrad MJ, Nof E, Michaud GF, John RM, Epstein LM, Stevenson WG, Jarolim P.
    J Interv Card Electrophysiol; 2016 Oct 15; 47(1):69-74. PubMed ID: 26971332
    [Abstract] [Full Text] [Related]

  • 39. Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. The Murcia Atrial Fibrillation Project.
    Esteve-Pastor MA, Rivera-Caravaca JM, Roldan V, Vicente V, Valdés M, Marín F, Lip GYH.
    Thromb Haemost; 2017 Oct 05; 117(10):1848-1858. PubMed ID: 28799620
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.